147 related articles for article (PubMed ID: 8077867)
1. [Ambulatory heparin-antivitamin K relay].
Plettner JL
J Mal Vasc; 1994; 19(2):154-7. PubMed ID: 8077867
[TBL] [Abstract][Full Text] [Related]
2. [Duration of antivitamin K therapy in venous thromboembolic disease. Certainties and uncertainties].
Ferrari E; Schiano N; Benhamou M; Baudouy M
Arch Mal Coeur Vaiss; 2001 Nov; 94(11 Suppl):1301-6. PubMed ID: 11794973
[TBL] [Abstract][Full Text] [Related]
3. [Complications and risks associated with an anticoagulation therapy combining low molecular weight heparin and Warfarin after total replacement of large joints--our experience].
Míka P; Behounek J; Skoták M; Nevsímal L
Acta Chir Orthop Traumatol Cech; 2004; 71(4):237-44. PubMed ID: 15456102
[TBL] [Abstract][Full Text] [Related]
4. [Duration of antivitamin K therapy in venous thromboembolic disease].
Ferrari E; Baudouy M; Morand P
Arch Mal Coeur Vaiss; 1995 Dec; 88(12):1891-4. PubMed ID: 8729371
[TBL] [Abstract][Full Text] [Related]
5. [-Anticoagulant drugs-].
Gulba DC
Herz; 1996 Feb; 21(1):12-27. PubMed ID: 8647576
[TBL] [Abstract][Full Text] [Related]
6. [Which antithrombotic agents should be prescribed in deep venous thrombosis of the limbs?].
Fiessinger JN
Presse Med; 1994 Mar; 23(11):509-10. PubMed ID: 8022737
[TBL] [Abstract][Full Text] [Related]
7. [When is antivitamin K therapy indicated in the stable coronary patient?].
Ferrari E; Serre S; Lesto I; Berkane N; Baudouy M
Arch Mal Coeur Vaiss; 2001 Nov; 94(11 Suppl):1274-7. PubMed ID: 11794969
[TBL] [Abstract][Full Text] [Related]
8. Initial treatment of venous thromboembolism.
Becattini C; Agnelli G; Emmerich J; Bura A; Weitz JI
Thromb Haemost; 2006 Sep; 96(3):242-50. PubMed ID: 16953263
[TBL] [Abstract][Full Text] [Related]
9. [Comparative study of the efficacy of a low dose of antivitamin K and a preventive dose of low molecular weight heparin in the prevention of relapses of deep venous thrombosis after curative treatment in the aged subject].
Pistorius MA; Said L; Planchon B
J Mal Vasc; 1994; 19(1):68. PubMed ID: 8027686
[No Abstract] [Full Text] [Related]
10. [Prevention of immunoallergic thrombopenia induced by heparin].
Grouille D; Sardin B; Colin D; Boulogne P
Cah Anesthesiol; 1988; 36(4):261-3. PubMed ID: 3167631
[No Abstract] [Full Text] [Related]
11. Single-arm study of bridging therapy with low-molecular-weight heparin for patients at risk of arterial embolism who require temporary interruption of warfarin.
Kovacs MJ; Kearon C; Rodger M; Anderson DR; Turpie AG; Bates SM; Desjardins L; Douketis J; Kahn SR; Solymoss S; Wells PS
Circulation; 2004 Sep; 110(12):1658-63. PubMed ID: 15364803
[TBL] [Abstract][Full Text] [Related]
12. [Before administering oral anticoagulant therapy with vitamin K antagonists, should heparin be administered, even when therapy is purely of preventive intent without an acute clinical manifestation?].
Seitz R
Internist (Berl); 1995 Nov; 36(11):1099-100. PubMed ID: 8543448
[No Abstract] [Full Text] [Related]
13. [Heparins and antivitamins K].
Langer B
Rev Paul Med; 1990; 108(4):183-8. PubMed ID: 2095622
[No Abstract] [Full Text] [Related]
14. [Thromboembolic complications following hip arthroplasty. Role of systematic heparin therapy (130 cases)].
Raimbeau G; Galland F; Pidhorz L
Ann Chir; 1983 May; 37(4):291-5. PubMed ID: 6625504
[No Abstract] [Full Text] [Related]
15. [Patient card. Tips on taking an oral anticoagulant (antivitamin K)].
Rev Prat; 2004 Feb; 54(3):310. PubMed ID: 15134240
[No Abstract] [Full Text] [Related]
16. [Prescription and monitoring of antithrombotic treatment. First part: anticoagulants].
Boneu B
Rev Prat; 2004 Mar; 54(6):651-6. PubMed ID: 15222619
[No Abstract] [Full Text] [Related]
17. [Monitoring antivitamin K treatment: a notebook for the patient].
Buxeraud J
Rev Infirm; 2004 Apr; (100):38-41. PubMed ID: 15222184
[No Abstract] [Full Text] [Related]
18. [Treatment of venous thrombosis in cancer patients: practical aspects].
Laza-Achille M; Desruennes E; Di Palma M
Bull Cancer; 2006 Mar; 93(3):271-81. PubMed ID: 16567314
[TBL] [Abstract][Full Text] [Related]
19. [Laboratory control of the effect of anti-vitamins K on blood coagulation].
Langer B; Muraco B; Manasterski J; Bechara MJ; Sitrângulo Júnior C; Puech-Leão LE
Rev Hosp Clin Fac Med Sao Paulo; 1984; 39(1):12-7. PubMed ID: 6484435
[No Abstract] [Full Text] [Related]
20. [Death of Sintrom?].
Vogel J
Rev Med Suisse; 2012 Jan; 8(325):164-5. PubMed ID: 22338498
[No Abstract] [Full Text] [Related]
[Next] [New Search]
